| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.669 | 17.557 | - | 469 | 0 | 0 | 0 | - | - | - |
| Total Income - EUR | 12.669 | 18.244 | - | 469 | 0 | 0 | 0 | - | - | - |
| Total Expenses - EUR | 4.592 | 10.687 | - | 3.760 | 3.034 | 3.075 | 3.447 | - | - | - |
| Gross Profit/Loss - EUR | 8.076 | 7.557 | - | -3.291 | -3.034 | -3.075 | -3.447 | - | - | - |
| Net Profit/Loss - EUR | 7.696 | 7.010 | - | -3.305 | -3.034 | -3.075 | -3.447 | - | - | - |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 0 | - | - | - |
Check the financial reports for the company - A Popovici Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 1.884 | 805 | 69 | 0 | - | - | - |
| Current Assets | 29.187 | 29.903 | - | 38.078 | 34.724 | 31.702 | 27.643 | - | - | - |
| Inventories | 5 | 0 | - | 0 | 0 | 0 | 0 | - | - | - |
| Receivables | 999 | 1.403 | - | 0 | 0 | 0 | 0 | - | - | - |
| Cash | 28.184 | 28.500 | - | 38.078 | 34.724 | 31.702 | 27.643 | - | - | - |
| Shareholders Funds | 29.084 | 29.117 | - | 37.198 | 33.444 | 29.736 | 25.629 | - | - | - |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | - | - | - |
| Debts | 103 | 786 | - | 2.764 | 2.085 | 2.036 | 2.014 | - | - | - |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - A Popovici Med S.r.l.